Geneva Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Geneva Advisors's CELG Position: Q2 2017 in Review
Geneva Advisors reduced its Celgene Corp (CELG) stake by 33% in Q2 2017, selling an estimated $38.2M and leaving 637,735 shares worth $82.8M. The position accounts for 1.43% of the portfolio, ranked #18.
Geneva Advisors first reported a position in CELG in Q2 2013 and has held it in 17 quarters since. The position peaked at $149M in Q1 2015. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.
- Geneva Advisors held 637,735 shares of Celgene Corp worth $82.8M as of Q2 2017.
- Geneva Advisors sold 312,110 Celgene Corp shares in Q2 2017, an estimated $38.2M.
- Celgene Corp made up 1.43% of Geneva Advisors's portfolio in Q2 2017, its #18 holding.
- Geneva Advisors first reported a position in Celgene Corp in Q2 2013 and has held it in 17 quarters since.
- Geneva Advisors's Celgene Corp position peaked at $149M in Q1 2015.
- 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.
Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.